SANA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sana Biotechnology Inc (SANA).


$363.93M Market Cap.

As of 03/17/2025 5:00 PM ET (MRY) • Disclaimer

SANA Market Cap. (MRY)


SANA Shares Outstanding (MRY)


SANA Assets (MRY)


Total Assets

$501.02M

Total Liabilities

$250.52M

Total Investments

$24.93M

SANA Income (MRY)


Revenue

$0

Net Income

-$266.76M

Operating Expense

$272.72M

SANA Cash Flow (MRY)


CF Operations

-$223.15M

CF Investing

$17.45M

CF Financing

$199.75M

SANA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

SANA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$501,020,000 (-11.37%)

$565,299,000 (-31.29%)

$822,720,000 (-27.15%)

$1,129,407,000 (54.65%)

Assets Current

$160,808,000 (-24.69%)

$213,515,000 (-51.96%)

$444,437,000 (-20.37%)

$558,101,000 (45.16%)

Assets Non-Current

$340,212,000 (-3.29%)

$351,784,000 (-7.01%)

$378,283,000 (-33.79%)

$571,306,000 (65.20%)

Goodwill & Intangible Assets

$199,822,000 (0.00%)

$199,822,000 (0.00%)

$199,822,000 (0.00%)

$199,822,000 (0.00%)

Shareholders Equity

$250,504,000 (-12.87%)

$287,506,000 (-42.42%)

$499,315,000 (-31.46%)

$728,502,000 (272.97%)

Property Plant & Equipment Net

$135,269,000 (-7.09%)

$145,592,000 (-8.66%)

$159,403,000 (-1.47%)

$161,784,000 (47.15%)

Cash & Equivalents

$131,398,000 (-4.33%)

$137,349,000 (-24.89%)

$182,865,000 (-27.73%)

$253,029,000 (99.32%)

Accumulated Other Comprehensive Income

$14,000 (123.33%)

-$60,000 (98.61%)

-$4,327,000 (-216.76%)

-$1,366,000 (-4653.33%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$24,931,000 (-65.22%)

$71,678,000 (-72.61%)

$261,657,000 (-47.95%)

$502,667,000 (75.03%)

Investments Current

$24,931,000 (-65.22%)

$71,678,000 (-71.00%)

$247,198,000 (-17.04%)

$297,967,000 (17.56%)

Investments Non-Current

$0 (0%)

$0 (0%)

$14,459,000 (-92.94%)

$204,700,000 (506.86%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$5,210,000 (26.83%)

$4,108,000 (43.79%)

$2,857,000 (28.75%)

$2,219,000 (-1.51%)

Accumulated Retained Earnings (Deficit)

-$1,604,850,000 (-19.94%)

-$1,338,091,000 (-26.85%)

-$1,054,836,000 (-34.31%)

-$785,360,000 (-82.88%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$94,197,000 (-9.51%)

$104,096,000 (-3.84%)

$108,253,000 (-2.42%)

$110,943,000 (54.28%)

Debt Current

$12,534,000 (-5.01%)

$13,195,000 (6.47%)

$12,393,000 (35.31%)

$9,159,000 (146.74%)

Debt Non-Current

$81,663,000 (-10.16%)

$90,901,000 (-5.17%)

$95,860,000 (-5.82%)

$101,784,000 (49.25%)

Total Liabilities

$250,516,000 (-9.82%)

$277,793,000 (-14.10%)

$323,405,000 (-19.33%)

$400,905,000 (34.27%)

Liabilities Current

$45,433,000 (-29.55%)

$64,487,000 (-42.17%)

$111,504,000 (12.36%)

$99,235,000 (215.52%)

Liabilities Non-Current

$205,083,000 (-3.86%)

$213,306,000 (0.66%)

$211,901,000 (-29.76%)

$301,670,000 (12.93%)

SANA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$64,040,000 (-12.63%)

$73,299,000 (2.43%)

$71,561,000 (41.96%)

$50,410,000 (78.32%)

Research & Development Expense

$208,683,000 (-5.08%)

$219,842,000 (9.37%)

$201,003,000 (-34.42%)

$306,499,000 (18.85%)

Operating Expenses

$272,723,000 (-6.97%)

$293,141,000 (7.55%)

$272,564,000 (-23.63%)

$356,909,000 (24.73%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$266,759,000 (5.82%)

-$283,255,000 (-5.11%)

-$269,476,000 (24.29%)

-$355,928,000 (-24.75%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$266,759,000 (5.82%)

-$283,255,000 (-5.11%)

-$269,476,000 (24.29%)

-$355,928,000 (-24.75%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$266,759,000 (5.82%)

-$283,255,000 (-5.11%)

-$269,476,000 (24.29%)

-$355,928,000 (-24.75%)

Weighted Average Shares

$230,891,000 (18.69%)

$194,541,000 (3.29%)

$188,344,000 (13.17%)

$166,433,000 (1178.88%)

Weighted Average Shares Diluted

$230,891,000 (18.69%)

$194,541,000 (3.29%)

$188,344,000 (13.17%)

$166,433,000 (1178.88%)

Earning Before Interest & Taxes (EBIT)

-$266,759,000 (5.82%)

-$283,255,000 (-5.11%)

-$269,476,000 (24.29%)

-$355,928,000 (-24.75%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$272,723,000 (6.97%)

-$293,141,000 (-7.55%)

-$272,564,000 (23.63%)

-$356,909,000 (-24.73%)

SANA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$17,453,000 (-89.85%)

$172,012,000 (-18.31%)

$210,562,000 (185.66%)

-$245,798,000 (2.68%)

Net Cash Flow from Financing

$199,749,000 (531.20%)

$31,646,000 (544.13%)

$4,913,000 (-99.22%)

$631,751,000 (45.00%)

Net Cash Flow from Operations

-$223,153,000 (12.00%)

-$253,582,000 (12.57%)

-$290,050,000 (-15.53%)

-$251,054,000 (-81.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$5,951,000 (88.08%)

-$49,924,000 (33.06%)

-$74,575,000 (-155.28%)

$134,899,000 (198.83%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$50,883,000 (-73.50%)

$192,044,000 (-17.02%)

$231,438,000 (209.50%)

-$211,362,000 (7.58%)

Capital Expenditure

-$33,430,000 (-66.88%)

-$20,032,000 (4.04%)

-$20,876,000 (30.09%)

-$29,862,000 (-25.09%)

Issuance (Repayment) of Debt Securities

$7,744,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$192,005,000 (506.73%)

$31,646,000 (544.13%)

$4,913,000 (-99.22%)

$631,751,000 (423893.96%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$37,678,000 (6.04%)

$35,533,000 (-7.31%)

$38,337,000 (71.44%)

$22,362,000 (283.70%)

Depreciation Amortization & Accretion

$27,072,000 (-28.42%)

$37,822,000 (36.39%)

$27,731,000 (54.80%)

$17,914,000 (76.13%)

SANA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-84.80% (-7.48%)

-78.90% (-76.12%)

-44.80% (-5.41%)

-42.50% (-142.00%)

Return on Average Assets (ROAA)

-45.20% (-5.85%)

-42.70% (-48.26%)

-28.80% (0.35%)

-28.90% (41.97%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-90.60% (-2.14%)

-88.70% (-82.14%)

-48.70% (28.70%)

-68.30% (27.49%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-1.41 (49.73%)

-2.79 (-1.19%)

-2.76 (61.82%)

-7.23

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.45 (-48.07%)

2.8 (85.42%)

1.51 (-62.40%)

4.01

Debt to Equity Ratio (D/E)

1 (3.52%)

0.97 (49.07%)

0.65 (17.82%)

0.55 (177.57%)

Earnings Per Share (EPS)

-1.16 (20.55%)

-1.46 (-2.10%)

-1.43 (33.18%)

-2.14 (90.24%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.11 (20.98%)

-1.41 (14.84%)

-1.65 (2.19%)

-1.69 (86.43%)

Book Value Per Share (BVPS)

1.08 (-26.59%)

1.48 (-44.25%)

2.65 (-39.43%)

4.38 (113.52%)

Tangible Assets Book Value Per Share (TABVPS)

1.3 (-30.55%)

1.88 (-43.18%)

3.31 (-40.79%)

5.58 (-86.30%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (66.67%)

-3 (0.00%)

-3 (57.14%)

-7

Enterprise Value Over EBITDA (EV/EBITDA)

-1.37 (53.77%)

-2.97 (-3.20%)

-2.88 (62.29%)

-7.63

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.54 (6.89%)

3.31 (-16.93%)

3.99 (-29.13%)

5.62 (-53.99%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$256,583,000 (6.22%)

-$273,614,000 (12.00%)

-$310,926,000 (-10.68%)

-$280,916,000 (-73.56%)

Enterprise Value (EV)

$329,184,289 (-54.84%)

$728,887,489 (4.77%)

$695,706,458 (-73.03%)

$2,579,550,128

Earnings Before Tax (EBT)

-$266,759,000 (5.82%)

-$283,255,000 (-5.11%)

-$269,476,000 (24.29%)

-$355,928,000 (-24.75%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$239,687,000 (2.34%)

-$245,433,000 (-1.53%)

-$241,745,000 (28.48%)

-$338,014,000 (-22.85%)

Invested Capital

$218,564,000 (-18.37%)

$267,737,000 (-38.70%)

$436,782,000 (-36.54%)

$688,264,000 (55.02%)

Working Capital

$115,375,000 (-22.58%)

$149,028,000 (-55.24%)

$332,933,000 (-27.44%)

$458,866,000 (29.98%)

Tangible Asset Value

$301,198,000 (-17.59%)

$365,477,000 (-41.33%)

$622,898,000 (-32.99%)

$929,585,000 (75.24%)

Market Capitalization

$363,928,289 (-54.75%)

$804,303,489 (6.76%)

$753,369,458 (-74.23%)

$2,923,134,128

Average Equity

$314,443,250 (-12.45%)

$359,162,250 (-40.30%)

$601,623,500 (-28.09%)

$836,616,750 (396.82%)

Average Assets

$590,114,000 (-10.95%)

$662,703,500 (-29.11%)

$934,881,000 (-24.09%)

$1,231,615,250 (115.04%)

Invested Capital Average

$294,541,500 (-7.81%)

$319,508,750 (-42.28%)

$553,575,750 (6.22%)

$521,143,750 (72.02%)

Shares

223,268,889 (13.26%)

197,133,208 (3.36%)

190,726,445 (1.00%)

188,832,954 (3.58%)